Selvita completes acquisition of PozLab and significantly expands its drug development capabilities

KRAKÓW, Poland, May 7, 2024 /PRNewswire/ — Selvita S.A. [WSE: SLV] announced today completion of a strategic transaction in which it has acquired 100% of shares in PozLab. The closing of the transaction comes shortly after the announcement of the transaction on March 27, 2024. PozLab is…